Related Experiment Video
Updated: Jan 31, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
PTEN-opathies: from biological insights to evidence-based precision medicine
Lamis Yehia1, Joanne Ngeow1,2,3,4, Charis Eng1,5,6,7
1Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Abstract:
The tumor suppressor phosphatase and tensin homolog (PTEN) classically counteracts the PI3K/AKT/mTOR signaling cascade. Germline pathogenic PTEN mutations cause PTEN hamartoma tumor syndrome (PHTS), featuring various benign and malignant tumors, as well as neurodevelopmental disorders such as autism spectrum disorder. Germline and somatic mosaic mutations in genes encoding components of the PI3K/AKT/mTOR pathway downstream of PTEN predispose to syndromes with partially overlapping clinical features, termed the "PTEN-opathies." Experimental models of PTEN pathway disruption uncover the molecular and cellular processes influencing clinical phenotypic manifestations. Such insights not only teach us about biological mechanisms in states of health and disease, but also enable more accurate gene-informed cancer risk assessment, medical management, and targeted therapeutics. Hence, the PTEN-opathies serve as a prototype for bedside to bench, and back to the bedside, practice of evidence-based precision medicine.
Insights
Mutations in the PTEN gene cause PTEN hamartoma tumor syndrome (PHTS) and related "PTEN-opathies," impacting tumor development and neurodevelopment. Understanding these conditions advances precision medicine for cancer and developmental disorders.
Area of Science:
- Genetics and Molecular Biology
- Oncology
- Developmental Neuroscience
Background:
- The tumor suppressor Phosphatase and Tensin homolog (PTEN) is a key negative regulator of the PI3K/AKT/mTOR signaling pathway.
- Germline mutations in PTEN lead to PTEN hamartoma tumor syndrome (PHTS), characterized by diverse tumors and neurodevelopmental issues like autism spectrum disorder.
- Syndromes with overlapping features, termed "PTEN-opathies," arise from mutations in genes downstream of PTEN within the PI3K/AKT/mTOR pathway.
Purpose of the Study:
- To explore the molecular and cellular mechanisms underlying PTEN-opathies.
- To enhance gene-informed cancer risk assessment and medical management strategies.
- To highlight the role of PTEN-opathies as a model for precision medicine.
Main Methods:
- Review of experimental models investigating PTEN pathway disruption.
- Analysis of clinical data linking PTEN mutations to phenotypic manifestations.
- Integration of genetic, cellular, and clinical insights.
Main Results:
- PTEN pathway disruption influences a spectrum of clinical phenotypes, including neoplastic and neurodevelopmental disorders.
- Experimental models elucidate the biological processes affected by PTEN mutations.
- Understanding PTEN-opathies facilitates improved diagnostic and therapeutic approaches.
Conclusions:
- PTEN-opathies exemplify the translation of basic research into clinical applications.
- Insights from PTEN-opathies advance personalized medicine for cancer and rare genetic disorders.
- This research underscores the importance of the PTEN pathway in both cancer suppression and normal development.
Related Concept Videos
The Evidence for Evolution
What is Conservation Biology?
Introduction to Biological Bases of Psychology
The nervous system, the cornerstone of...
Uncertainty in Measurement: Accuracy and Precision
Microorganisms in Medicine and Therapeutics
Accuracy and Precision

